Evidence map›Paper›PMID 41465514›Full record

ReviewInternational journal of molecular sciences2025

The Determinant of Tau Spreading in Alzheimer's Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?

Yuichi Riku, Jean-Pierre Brion, Kunie Ando, Toshiki Uchihara, Yasushi Iwasaki

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuichi RikuInstitute for Medical Science of Aging, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.ORCID 0000-0002-6493-8976
Jean-Pierre BrionAlzheimer and Other Tauopathies Research Group, ULB Center for Diabetes Research (UCDR), Faculty of Medicine, ULB Neuroscience Institute (UNI), Université Libre de Bruxelles, 1050 Bruxelles, Belgium.
Kunie AndoAlzheimer and Other Tauopathies Research Group, ULB Center for Diabetes Research (UCDR), Faculty of Medicine, ULB Neuroscience Institute (UNI), Université Libre de Bruxelles, 1050 Bruxelles, Belgium.ORCID 0000-0003-3822-175X
Toshiki UchiharaOkinawa Chubu Hospital, Uruma 904-2293, Okinawa, Japan.
Yasushi IwasakiInstitute for Medical Science of Aging, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.

Funding

JSPS-KAKENHI 23K06935, 25K22597, and 25K10781MHLW Research on rare and intractable diseases Program JPMH23FC1008
6 · The paper itself

Abstract

Alzheimer's disease (AD) is neuropathologically characterized by tau-immunopositive neurofibrillary tangles (NFTs) and amyloid-β (Aβ)-immunopositive senile plaques. According to the widely accepted amyloid cascade hypothesis, Aβ pathology represents the upstream event in AD pathophysiology and induces tau aggregation. However, numerous studies have suggested that tau aggregates correlate more closely with neuronal loss and regional brain atrophy than with Aβ depositions. Tau aggregation in AD demonstrates a hierarchical spreading pattern beginning in the transentorhinal cortex, but the mechanisms underlying this spreading manner of lesions remain to be elucidated. This review aims to address current controversies regarding tau pathology in AD from the perspectives of both the 'amyloid cascade' and 'tauopathy' hypotheses. From the 'amyloid cascade' viewpoint, Aβ deposition prominently involves distal axon and axon terminals, and in some regions, there are anatomical correspondences between axonal Aβ pathology and cytoplasmic tau aggregations (e.g., a close relationship between senile plaques in the molecular layer of the hippocampal dentate gyrus and NFTs in the transentorhinal cortex). Nevertheless, this model cannot explain the whole body of hierarchical spreading of tau aggregation because notable spaciotemporal discrepancies also exist in many regions. From the 'tauopathy' perspective, the distribution of tau aggregates in AD involves key nodes within the memory circuits. Also, experimental studies have suggested that patient-derived tau exhibits seeding and neuron-to-neuron propagation properties. Interestingly, tau aggregation in AD appears to spread laterally in a proximity-dependent, cortico-cortical fashion rather than along long-range memory circuits. This contrasts with the system-selective, poly-nodal degenerations seen in four-repeat tauopathies, amyotrophic lateral sclerosis, or spinocerebellar degenerations. Moreover, the proportions of three-repeat and four-repeat isoforms shift during the maturation of NFTs in AD. Overall, spreading patterns of tau-pathology in AD cannot be fully explained by Aβ pathology and also differ from the system degeneration seen in other tauopathies.

Indexed as

Alzheimer DiseasePlaque, Amyloidtau ProteinsAmyloid beta-PeptidesAnimalsBrainHumansNeurofibrillary TanglesAmyloid beta-Peptidestau ProteinsAlzheimer’s diseaseamyloid cascadeautopsyAβneurofibrillary tangleneuropathologyprotein propagationsenile plaquetautauopathy

Identifiers

PMID41465514
PMCPMC12733252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.